These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1871038)

  • 1. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.
    Tozer TN; Rigod J; McLeod AD; Gungon R; Hoag MK; Friend DR
    Pharm Res; 1991 Apr; 8(4):445-54. PubMed ID: 1871038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.
    Haeberlin B; Rubas W; Nolen HW; Friend DR
    Pharm Res; 1993 Nov; 10(11):1553-62. PubMed ID: 8290467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug glycosides: potential prodrugs for colon-specific drug delivery.
    Friend DR; Chang GW
    J Med Chem; 1985 Jan; 28(1):51-7. PubMed ID: 3965714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis.
    Nolen H; Fedorak RN; Friend DR
    J Pharm Sci; 1995 Jun; 84(6):677-81. PubMed ID: 7562403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria.
    Friend DR; Chang GW
    J Med Chem; 1984 Mar; 27(3):261-6. PubMed ID: 6699871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
    McLeod AD; Friend DR; Tozer TN
    J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome.
    Nolen HW; Friend DR
    Pharm Res; 1994 Dec; 11(12):1707-11. PubMed ID: 7899232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract].
    Zhou SY; Mei QB; Zhou J; Liu L; Li C; Zhao DH
    Yao Xue Xue Bao; 2001 May; 36(5):325-8. PubMed ID: 12584851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration.
    Minami K; Hirayama F; Uekama K
    J Pharm Sci; 1998 Jun; 87(6):715-20. PubMed ID: 9607948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative anti-inflammatory effect of oral dexamethasone-beta-D-glucoside and dexamethasone in experimental inflammatory bowel disease in guinea-pigs.
    Friend DR; Phillips S; McLeod A; Tozer TN
    J Pharm Pharmacol; 1991 May; 43(5):353-5. PubMed ID: 1680179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression.
    Fedorak RN; Haeberlin B; Empey LR; Cui N; Nolen H; Jewell LD; Friend DR
    Gastroenterology; 1995 Jun; 108(6):1688-99. PubMed ID: 7768373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting.
    Pang YN; Zhang Y; Zhang ZR
    World J Gastroenterol; 2002 Oct; 8(5):913-7. PubMed ID: 12378641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the enzyme dependant colon targeting prodrug--dexamethasone succinate dextran and its tablets].
    Pang YN; Zhang ZR; Pang QJ; Li TL
    Yao Xue Xue Bao; 2001 Aug; 36(8):625-30. PubMed ID: 12579944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.
    Kim I; Kong H; Lee Y; Hong S; Han J; Jung S; Jung Y; Kim YM
    Pharm Res; 2009 Feb; 26(2):415-21. PubMed ID: 18958401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro properties of dexamethasone 21-sulfate sodium as a colon-specific prodrug of dexamethasone.
    Kim IH; Kong HS; Choi BI; Kim YS; Kim HJ; Yang YW; Jung YJ; Kim YM
    Drug Dev Ind Pharm; 2006 Mar; 32(3):389-97. PubMed ID: 16556543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific delivery.
    Uekama K; Minami K; Hirayama F
    J Med Chem; 1997 Aug; 40(17):2755-61. PubMed ID: 9276021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetic study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery.
    Leopold CS; Friend DR
    J Pharmacokinet Biopharm; 1995 Aug; 23(4):397-406. PubMed ID: 8882747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of N-nicotinoyl-2-{2-(2-methyl-5-nitroimidazol-1-yl)ethyloxy}-D,L-glycine as a colon-specific prodrug of metronidazole.
    Kim D; Hong S; Jung S; Jung Y; Kim YM
    J Pharm Sci; 2009 Nov; 98(11):4161-9. PubMed ID: 19283770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Kim HH; Kong HS; Kim YM
    Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
    Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
    J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.